1. Valdoxan (Agomelatine) in the Treatment of Severe and Moderate Nonpsychotic Depression in Psychiatric Hospital Patients: Statistical Report of the VREMYA Observational Trial [in Russian], Moscow (2010).
2. M. C. Ivanov and G. E. Mazo, Polypharmacotherapeutic Approach to the Treatment of Refractory Depressive States: Improvements in Medical Techniques [in Russian], St. Petersburg (2007).
3. M. Lader, “Limitations of current methods of treating depression: impaired circadian rhythms as a potential therapeutic target,” Psikhiatr. Psikhofarmakoter., No. 5, 46–53 (2010).
4. G. E. Mazo, S. E. Gorbachev, and N. N. Petrova, “Therapeutically refractory depression: current approaches to diagnosis and treatment,” Vestn. SPb Univers., 2, No. 11, 87–96 (2008).
5. V. E. Medvedev, “Potentials for the use of melatoninergic agents in the treatment of depression in patients with cardiovascular diseases,” Psikhiatr. Psikhofarmakoter., No. 3, 19–23 (2010).